Little Green Pharma Ltd

ASX:LGP Stock Report

Market Cap: AU$31.9m

Little Green Pharma Future Growth

Future criteria checks 5/6

Little Green Pharma is forecast to grow earnings and revenue by 108.9% and 20.3% per annum respectively. EPS is expected to grow by 108.1% per annum. Return on equity is forecast to be 1.1% in 3 years.

Key information

108.9%

Earnings growth rate

108.08%

EPS growth rate

Pharmaceuticals earnings growth41.4%
Revenue growth rate20.3%
Future return on equity1.05%
Analyst coverage

Low

Last updated30 Apr 2025

Recent future growth updates

Recent updates

author-image

Little Green Pharma set to double revenue amidst European expansion

Revenue Growth:FY2024 Baseline: $25.6 million, up 29% from $19.9 million in FY2023.Assumption: If LGP maintains a similar growth rate—supported by new products, European expansion (e.g., Germany’s leg

Little Green Pharma Ltd's (ASX:LGP) Share Price Boosted 29% But Its Business Prospects Need A Lift Too

Feb 17
Little Green Pharma Ltd's (ASX:LGP) Share Price Boosted 29% But Its Business Prospects Need A Lift Too

Is Little Green Pharma (ASX:LGP) Using Debt Sensibly?

Jan 17
Is Little Green Pharma (ASX:LGP) Using Debt Sensibly?

Improved Revenues Required Before Little Green Pharma Ltd (ASX:LGP) Shares Find Their Feet

Nov 19
Improved Revenues Required Before Little Green Pharma Ltd (ASX:LGP) Shares Find Their Feet

The Market Doesn't Like What It Sees From Little Green Pharma Ltd's (ASX:LGP) Revenues Yet As Shares Tumble 27%

Jun 30
The Market Doesn't Like What It Sees From Little Green Pharma Ltd's (ASX:LGP) Revenues Yet As Shares Tumble 27%

Estimating The Fair Value Of Little Green Pharma Ltd (ASX:LGP)

Jun 17
Estimating The Fair Value Of Little Green Pharma Ltd (ASX:LGP)

Little Green Pharma (ASX:LGP) Has Debt But No Earnings; Should You Worry?

Mar 05
Little Green Pharma (ASX:LGP) Has Debt But No Earnings; Should You Worry?

Not Many Are Piling Into Little Green Pharma Ltd (ASX:LGP) Just Yet

Nov 01
Not Many Are Piling Into Little Green Pharma Ltd (ASX:LGP) Just Yet

A Look At The Intrinsic Value Of Little Green Pharma Ltd (ASX:LGP)

May 08
A Look At The Intrinsic Value Of Little Green Pharma Ltd (ASX:LGP)

Statutory Earnings May Not Be The Best Way To Understand Little Green Pharma's (ASX:LGP) True Position

Sep 06
Statutory Earnings May Not Be The Best Way To Understand Little Green Pharma's (ASX:LGP) True Position

What Type Of Shareholders Make Up Little Green Pharma Ltd's (ASX:LGP) Share Registry?

Feb 11
What Type Of Shareholders Make Up Little Green Pharma Ltd's (ASX:LGP) Share Registry?

Earnings and Revenue Growth Forecasts

ASX:LGP - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/2027501231
3/31/2026461231
3/31/202537-3-201
9/30/202429-913N/A
6/30/202427-901N/A
3/31/202426-8-10N/A
12/31/202326-6-3-1N/A
9/30/202325-3-5-2N/A
6/30/202322-6-8-4N/A
3/31/202320-9-12-7N/A
3/31/202214-24-33-23N/A
12/31/20211113-21-14N/A
9/30/2021918-14-10N/A
6/30/2021722-6-5N/A
3/31/202169-7-4N/A
12/31/20205-3-7-2N/A
9/30/20204-6-10-4N/A
6/30/20202-9-13-6N/A
3/31/20202-9-11-6N/A
12/31/20191-9-8-5N/A
9/30/20191-7-6-4N/A
6/30/20190-6-4-3N/A
6/30/20180-4N/A-2N/A
6/30/201700N/A0N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: LGP is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (3%).

Earnings vs Market: LGP is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: LGP is expected to become profitable in the next 3 years.

Revenue vs Market: LGP's revenue (20.3% per year) is forecast to grow faster than the Australian market (5.5% per year).

High Growth Revenue: LGP's revenue (20.3% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: LGP's Return on Equity is forecast to be low in 3 years time (1.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/22 19:39
End of Day Share Price 2025/05/22 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Little Green Pharma Ltd is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Cameron BellCanaccord Genuity